Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review

References

• Adams BB. 2002. Tinea corporis gladiatorum. J Am Acad Dermatol. 47:286–290.
   PubMed Web of Science ®Google Scholar
• Agarwal K, Manas DM, Hudson M. 1999. Terbinafine and fulminant hepatic failure. N Engl J Med. 340:1292–1293.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Katare OP. 2002. Preparation and in-vitro evaluation of miconazole nitrate loaded topical liposomes. Pharm Tech. 1–12.
   Google Scholar
• Aggarwal N, Goindi S. 2012. Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis—Dermatophytosis. Int J Pharm. 437:277–287.
   PubMed Web of Science ®Google Scholar
• Alagusundaram M, Madhu SCC, Umashankari K, Attuluri VB, Lavanya C, Ramkanth S. 2009. Microspheres as a novel drug delivery system- A review. Int J Chem Tech Res. 1:526–534.
   Google Scholar
• Albertini B, Passerini N, Sabatino MD, Vitali B, Brigidi P, Rodriguez R. 2009. Polymer–lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci. 36:591–601.
   PubMed Web of Science ®Google Scholar
• Amichai B, Grunwald M. 1998. Adverse drug reactions of the new oral antifungal agentsterbinafine, fluconazole, and itraconazole. Int J Dermatol. 37:410–415.
   PubMed Web of Science ®Google Scholar
• Arikan S, Rex JH. 2001. Lipid-based antifungal agents: current status. Curr Pharm Res. 7:393–415.
   PubMed Web of Science ®Google Scholar
• Arora R, Jain CP. 2007. Advances in niosomes as drug a carrier: A review. Asi J Pharm. 1: 29–39.
   Google Scholar
• Ataei S, Moazeni E, Gilani K, Ghaffari A, Asgharian R, Najafabi A. 2011. In-vitro evalauation of itraconazole loaded vesicles prepared from non ionic surfactant. J Pharm Sci. 1:50–52.
   Google Scholar
• Available at: http://www.drugbank.ca. Accessed on 20 February, 2012.
   Google Scholar
• Available at: http://www.mycology.adelaide.edu.au. Accessed on 12 January, 2012.
   Google Scholar
• Available at: http://www.rxlist.ca. Accessed on 20 February, 2011.
   Google Scholar
• Available at: http://www.freepatentsonline.com. Accessed on 15 December, 2012.
   Google Scholar
• Babel DE, Baughman SA. 1989. Evaluation of the adult carrier state in juvenile tinea capitis caused by Trichophyton tonsurans. J Am Acad Dermatol. 21:1209–1212.
   PubMed Web of Science ®Google Scholar
• Bachhav YG, Mondon K, Kalia YN, Gurny MM. 2011. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals. J Control Rel. 153:126–132.
   PubMed Web of Science ®Google Scholar
• Barot BS, Parejiya BP, Patel HK, Gohel MK, Shelat KP. 2011. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design. AAPS Pharm Sci Tech.
   PubMed Web of Science ®Google Scholar
• Barry BW. 2001. Is transdermal drug delivery research still important today?. Drug Discov Today. 6:967–971.
   PubMed Web of Science ®Google Scholar
• Bhalaria MK, Naik S, Misra AN. 2009. Ethosomes: a novel delivery system for antifungal drugs in treatment of topical fungal disease. Ind J Exp Bio. 47:368–375.
   PubMed Web of Science ®Google Scholar
• Bhalekar MR, Pokharkar V, Ashwini M, Patil N. 2009. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS Pharm Sci Tech. 10:289–296.
   PubMed Web of Science ®Google Scholar
• Bhatta RS, Chandasana H, Chhonker YS, Rathi C, Kumar D, Mitra K, Shukla PD. 2012. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in-vitro and pharmacokinetics studies. Int J Pharm. 432:105–112.
   PubMed Web of Science ®Google Scholar
• Blank IH, Moloney J, Emslie AG. 1984. The diffusion of water across the stratum corneum as a function of its water content. J Invest Dermatol. 82:183–190.
   Web of Science ®Google Scholar
• Brodell R, Elewski B. 2000. Antifungal drug interactions: avoidance requires more than memorization. Postgrad Med. 107:41–43.
   Web of Science ®Google Scholar
• Chowdhary A, Singh K. 2005. Spectrum of fungal keratitis in North India. Cornea. 24:8–15.
   PubMed Web of Science ®Google Scholar
• Chudasama A, Patel VK, Nivsarker M, Vasu K, Shishoo C. 2011. Investigation of microemulsion system for transdermal delivery of itraconazole. J Adv Pharm Tech Res. 2:30–38.
   PubMedGoogle Scholar
• Del RJ. 2000. Current management of onychomycosis and dermatomycoses. Curr Infect Dis Rep. 2:438–445.
   PubMedGoogle Scholar
• Derle DV, Sagar BSH. 1975. Microemulsion as a vehicle for transdermal permeation of nimesulide. Ind J Pharm Sci. 68:622–625.
   Google Scholar
• Devi M, Kumar SM, Mahadevan N. 2011. Amphotericin-B loaded vesicular systems for the treatment of topical fungal infection. Int J Rec Adv Pharm Res. 4:37–46.
   Google Scholar
• Dharma SK, Fishman PM, Peyman GA. 1986. A preliminary study of corneal penetration of I125- labeled iodoxuridine liposomes. Acta Ophthalmol (Copenh). 64:298–301.
   PubMed Web of Science ®Google Scholar
• Durden F, Elewski B. 1997. Fungal infections in HIV-infected patients. Semin Cutan Mecl Surg. 16:200–212.
   PubMed Web of Science ®Google Scholar
• Elewski B. 1999. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol. 133:1172–1173.
   Google Scholar
• Elewski B. 2000. Tinea capitis: a current perspective. J Am Acad Dermatol. 42:1–20.
   PubMed Web of Science ®Google Scholar
• El-Hadidy GN, Ibrahi HK, Mohamed MI, El-Millig MF. 2011. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm. 1–9.
   Google Scholar
• Evans E, Sigurgeirsson B. 1999. Double-blind, randomised study of continuous terbinafine comp intermittent itraconazole in treatment of toenail onychomycosis. BMJ. 318:1031–1035.
   PubMed Web of Science ®Google Scholar
• Faergemann J, Baran R. 2003. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol. 149:1–4.
   PubMed Web of Science ®Google Scholar
• Faraday M. 1857. Experimental relations of gold (and other metals) to light. Phil Trans Roy Soc Lond. 147:145–181.
   Google Scholar
• Fawzia SH, Ehub AF, Mohamed SAR, Dina F. 2010. Liposomes as an ocular delivery system of fluconazole: in-vitro studies. Acta Ophthalmol. 88:901–904.
   PubMed Web of Science ®Google Scholar
• Firthouse PUM, Halith SM, Wahab SU, Sirajudin M, Mohideen SK. 2011. Formulation and evaluation of miconazole niosomes. Int J Pharm Tech Res. 3:1019–1022.
   Google Scholar
• Fleece D, Gaughan JP, Aronoff SC. 2004. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. 114:1312–1315.
   PubMed Web of Science ®Google Scholar
• Friedberg ML, Pleyer U, Mondino BJ. 1991. Device drug delivery to the eye. Collagen shields, iontophoresis and pumps. Ophthalmology. 98:725–732.
   PubMed Web of Science ®Google Scholar
• Ghannoum M, Isham N, Sheehan D. 2006. Voriconazole susceptibility of dermatophyte isolates obtained from a large worldwide tinea capitis clinical trial. J Clin Microbiol. 44:2579–2580.
   PubMed Web of Science ®Google Scholar
• Goldstein A, Smith K, Ives T. 2000. Mycotic infections: effective management of conditions involving the skin, hair, and nails. Geriatrics. 55:40–52.
   PubMed Web of Science ®Google Scholar
• Gulati M, Bajad S, Singh S, Ferdous AJ, Singh M. 1998. Development of liposomal Amphotericin B formulation. J Microencapsul. 15:137–151.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Chow M, Daniel CR, Aly R. 2003. Treatments of tinea pedis. Dermatol Clin. 21:431–462.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Cooper EA, Ryder JE. 2004. Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol. 5:225–237.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Fleckman P, Baron R. 2000. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol. 43:S70–;S80.
   PubMed Web of Science ®Google Scholar
• Gupta M, Goyal AK, Paliwal SR, Paliwal R, Mishra N, Vaidya B, et al. 2010. Development & characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Lip Res. 20:341–350.
   Google Scholar
• Gupta M, Tiwari S, Vyas SP. 2011. Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis. Pharm Dev Tech. doi:10.3109/10837450.2011.598161.
   Web of Science ®Google Scholar
• Gupta M, Vyas SP. 2012. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 165:454–461.
   PubMed Web of Science ®Google Scholar
• Gupta S, Ahirwar D, Sharma NK, Jadhe D. 2009. Proniosomal gel as a carrier for improved transdermal delivery of griseofulvin: preparation an in-vitro characterization. Available at: http://www.pharmainfo.net/deenanath-jhade/publications/proniosomal-gel-carrier-improved transdermal-delivery-griseofulvin-prep. Accessed on 12 March, 2012.
   Google Scholar
• Hall M, Monka C, Krupp P. 1997. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients. Arch Dermatol. 133:1213–1219.
   PubMed Web of Science ®Google Scholar
• Hart R, Bell-Syer SE, Crawford F. 1999. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ. 319:79–82.
   PubMed Web of Science ®Google Scholar
• Hashem FM, Shaker DS, Ghorab MK, Nasir M, Ismail AA. 2011. Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. AAPS Pharm Sci Tech. 12:879–886.
   PubMed Web of Science ®Google Scholar
• Hu C, Rhodes DG. 1999. Proniosomes:a novel drug carrier preparation. Int J Pharm. 185:23–35.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain S II, Khare P, Gulbake A, Bansal D, Jain SK. 2010. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Del. 17:443–451.
   PubMed Web of Science ®Google Scholar
• Jaya RK, Deboroh E, Chuah CW, Selvadurai M, Sokkalingam AD. 2012. Development and evaluation of microemulsion based gel (MBGs) containing econazole nitrate for nail fungal infection. J Pharm Res. 5:2385–2390.
   Google Scholar
• Jaydeep DY, Priyanka RK, Kumar AV, Gurubas TS. 2011. Niosomes: a review. J Pharm Res. 4:632–636.
   Google Scholar
• Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, et al. 2002. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med. 137:105–109.
   PubMed Web of Science ®Google Scholar
• Jones MC, Leroux JC. 1999. Polymeric micelles- a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 48:101–111.
   PubMed Web of Science ®Google Scholar
• Kassem MAA, Esmat S, Bendas ER, El-Komy MHM. 2005. Efficacy of topical griseofulvin in treatment of tinea corporis. Mycoses. 49:232–235.
   Web of Science ®Google Scholar
• Kasting GB, Barai ND. 2003. Equilibrium water sorption in human stratum corneum. J Pharm Sci. 92:1624–1631.
   PubMed Web of Science ®Google Scholar
• Katz H. 1997. Possible drug interactions in oral treatment of onychomycosis. J Am Podiatr Med Assoc. 87:571–574.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. 2004. Vesicular systems in ocular delivery: an overview. Int J Pharm. 269:1–14.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Kakkar S. 2010. Topical delivery of antifungal agents. Expert Opin Drug Deliv. 7:1303–1327.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Rana C, Singh H. 2008. Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Ther. 24: 481–494.
   PubMed Web of Science ®Google Scholar
• Kazunori K, Harada A, Nagasaki Y. 2001. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Del Rev. 47:113–131.
   PubMed Web of Science ®Google Scholar
• Korting HC, Kiencke P, Nelles S. 2007. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis. Am J Clin Dermatol. 8:357–364.
   PubMed Web of Science ®Google Scholar
• Kotwani RN, Bodhe PV, Kirodian BG, Mehta KP, Ali US, Kshirsagar NA. 2003. Treatment of neonatal candidiasis with liposomal amphotericin B (L-AMP-LRC-1): phase II study. Ind Pediatr. 40:545–550.
   PubMedGoogle Scholar
• Kreilgaard M. 2002. Influence of microemulsions on cutaneous drug delivery. Bull Technique Gattefosse. 95:79–100.
   Google Scholar
• Kumar P, Mittal KL. 1998. Hand Book of Microemulsions: Science and Technology. New York, NY: Marcel Dekker, pp. 20–22.
   Google Scholar
• Kuvandik G, Cetin M, Genctoy G. 2007. The prevalence, epidemiology and risk factors for onychomycosis in hemodialysis patients. BMC Infect Dis. 7:102.
   PubMed Web of Science ®Google Scholar
• Laithy HM, Shaboury KMF. 2002. Development of cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS Pharm Sci Tech. 3:article 35.
   Google Scholar
• Lazaros GA, Papatheodoridis G, Delladetsima JK. 1996. Terbinafine-induced cholestatic liver disease. J Hepatol. 24:753–756.
   PubMed Web of Science ®Google Scholar
• Le BC, Acar L, Zia H. 1998. Ophthalmic drug delivery systems–recent advances. Prog Retin Eye Res. 17:33–58.
   PubMed Web of Science ®Google Scholar
• Lee EA, Balakrishnan P, Song CK, Choi JH, Noh GY, Park GC, et al. 2010. Microemulsion-based hydrogel formulation of itraconazole for topical delivery. J Pharm Invest. 40:305–311.
   Google Scholar
• Li L, Redding S, Dongari BA. 2007. Candida glabrata, an emerging oral opportunistic pathogen. J Dent Res. 86:204–215.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Capasso G, Maria L, Rodríguez G, Rabasco AM, Ghelardini C, Mura P. 2009. Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. J Lip Res. 1–8.
   Google Scholar
• Maheshwari RGS, Tekade KR, Sharma PA, Darwhekar G, Tyagi A, Patel PR, Jain DK. 2012. Ethosome and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm J20:161–170.
   PubMed Web of Science ®Google Scholar
• Maiti S, Dey P, Kaity S, Ray S, Maji S, Sa B. 2009. Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique. AAPS Pharm Sci Tech. 10:703–715.
   PubMed Web of Science ®Google Scholar
• Malhotra M, Jain NK. 1994. Niosomes as drug carriers. Ind Drugs. 31:81–86.
   Google Scholar
• Manzouri B, Vafidis GC, Wyse RK. 2001. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacother. 2:1849–1857.
   PubMedGoogle Scholar
• McClellan K, Wiseman L, Markham A. 1999. Terbinafine: an update of its use in superficial mycoses. Drugs. 58:179–202.
   PubMed Web of Science ®Google Scholar
• Mitkari BV, Korde SA, Mahadik KR, Kokare CK. 2010. Formulation and evaluation of topical liposomal gel for fluconazole. Ind J Pharm Edu Res. 44:324–333.
   Web of Science ®Google Scholar
• Mohanraj VJ, Chen Y. 2006. Nanoparticles – a review. Trop J Pharm Res. 5:561–573.
   Google Scholar
• Moossavi M, Bagheri B, Scher R. 2001. Systemic antifungal therapy. Dermatol Clin. 19:35–52.
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. 2002a. Solid lipid nanoparticles (SLN) nanostrucured lipid carrier (NLC) in cosmetic and dermatological preparation. Adv Drug Deliv Rev. 54:S131–S155.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mäder K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery-review of the state of the art. Eur J Pharm Biopharm. 50:161–177.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Souto EB. 2005. Nanostructured lipid carriers: a novel generation of solid lipid carriers. Pharm Tech Europe. 17:45–50.
   Google Scholar
• Müller RH, Radtke M, Wissing SA. 2002b. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 242:121–128.
   PubMed Web of Science ®Google Scholar
• Nagarsenker MS, Londhe VY, Nadkarni GD. 1999. Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. Int J Pharm. 190:63–70.
   PubMed Web of Science ®Google Scholar
• Nair R, Sevukarajan M, Mohammed B, Kumar J. 2010. Formulation of microemulsion based vaginal gel-in vitro and in vivo evaluation. Der Pharm Let. 2:99–105.
   Google Scholar
• Ning M, Yingzhi G, Huaizhong P, Xianli C, Zhongwei G. 2005. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm. 31:375–383.
   PubMed Web of Science ®Google Scholar
• Norbert M, David BF, Pieter RC. 2001. Developments in liposomal drug delivery systems. Expert Opin Biol Ther. 1:1–25.
   Web of Science ®Google Scholar
• Okada H, Toguchi H. 1995. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst. 12:1–99.
   PubMed Web of Science ®Google Scholar
• Ola HE, Soad AY, Omaima NE. 2010. Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes. Saudi Pharm J. 18:217–224.
   PubMedGoogle Scholar
• Paolicellia P, Correntea F, Serricchioa D, Cerretoa F, Cesaa S, Titab B, et al. 2011. The system SLN-Dextran hydrogel: An application for the topical delivery of Ketoconazole. J Chem Pharm Res. 3:410–421.
   Google Scholar
• Patel MR, Patel BR, Parikh RJ, Bhatt KK, Solanki BA. 2010. Investigating the effect of vehicle on in-vitro skin permeation of ketoconazole applied in O/W microemulsions. Acta Pharm Sci. 52:65–87.
   Google Scholar
• Patel PR, Patel HH, Baria HA. 2009. Formulation and evaluation of carbopol gel containing liposomes of ketoconazole. Int J Drug Del Tech. 1:42–45.
   Google Scholar
• Paul BK, Moulik SP. 1997. Microemulsions: over view. J Disp Sci Technol. 18:301–367.
   Web of Science ®Google Scholar
• Perveze Z, Johnson MW, Rublin RA. 2007. Terbinafine-induced hepatic failure requiring liver trans-plantation. Liver Transpl. 13:162–164.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Boyken L. 2004. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol. 42:3142–3146.
   PubMed Web of Science ®Google Scholar
• Piemi MPY, Korner D, Benita S, Marty JP. 1999. Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J Control Rel. 58:177–187.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Noonan JS. 1998. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 87:1479–1488.
   PubMed Web of Science ®Google Scholar
• Rangel TR. 1999. Fungal keratitis, ocular immunology and uveitis foundation: massachusetts Eye Research and Surgery Institution.
   Google Scholar
• Rivera PA, Martinez-oharriz MC, Rubio M, Irache JM, Espuelas S. 2004. Fluconazole encapsulation in PLGA microspheres by spray-drying. J Microencapsul. 21:203–211.
   PubMed Web of Science ®Google Scholar
• Robert EM, Kalia YN. 2006. New developments in topical antifungal therapy. Am J Drug Deliv. 4:231–247.
   Google Scholar
• Roberts BJ, Friedlander SF. 2005. Tinea capitis: a treatment update. Pediatr Ann. 34:191–200.
   PubMed Web of Science ®Google Scholar
• Salerno C, Adriana MC, Carlos B. 2011. Study of in-vitro release and percutaneous absorption of fluconazole from topical dosage form. AAPS Pharm Sci Tech. 11;986–993.
   Web of Science ®Google Scholar
• Sathali AAH, Rajalakhmi G. 2010. Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride. Int J Pharm Tech Res. 2:2081–2089.
   Google Scholar
• Scher RK, Tavakkol A, Sigurgeirsson B. 2007. Onychomycosis: diagnosis and definition of cure. JAAD. 56:939–944.
   PubMed Web of Science ®Google Scholar
• Schulman JH, Stoeckenius W, Prince LM. 1959. Mechanism of formation and structure of micro emulsions by electron microscopy. J Phys Chem. 63:1677–1680.
   Web of Science ®Google Scholar
• Sessa G, Weissmann C. 1968. Phospholipid spherules (liposomes) as a model for biological membranes. J Lipid Res. 9:310–318.
   PubMed Web of Science ®Google Scholar
• Shah RR, Magdum CS, Wadkar AK, Naikwade NS. 2009. Fluconazole topical microemulsion: preparation and evaluation. Res J Pharm Tech. 2:353–357.
   Google Scholar
• Shinoda K, Friberg S. 1975. Microemulsions- colloidal aspects. Adv Colloid Interface Sci. 4:281–300.
   Web of Science ®Google Scholar
• Singh P, Prakash D, Ramesh B, Singh N, Mani TT. 2011. Biodegradable polymeric microspheres as drug carriers; A review. Ind J Nov Drug Del. 3:70–82.
   Google Scholar
• Souto EB, Muller RH. 2005. SLN and NLC for topical delivery of ketoconazole. J Microencapsul. 22:501–510.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. 2004. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 278:71–77.
   PubMed Web of Science ®Google Scholar
• Stary A, Sarnow E. 1998. Fluconazole in the treatment of tinea corporis and tinea cruris. Dermatology. 196:237–241.
   PubMed Web of Science ®Google Scholar
• Sutton D, Nasongkla N, Blanco E, Gao J. 2007. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res. 24:1029–1045.
   PubMed Web of Science ®Google Scholar
• Svejgaard E. 1997. Recalcitrant dermatophyte infection. Dermatol Ther. 3:75–78.
   Google Scholar
• Szepietowski JC, Salomon J. 2007. Do fungi play a role in psoriatic nails?. Mycoses. 50:437–442.
   PubMed Web of Science ®Google Scholar
• Thomas PA, Geraldine P, Kaliamurthy J. 1997. Current perspectives in mycotic keratitis: diagnosis, management and pathogenesis. Adv Med Myco. 2:111–131.
   Google Scholar
• Thomas PA. 1994. Mycotic keratitis: an underestimated mycosis. J Med Vet Mycol. 32:235–254.
   PubMedGoogle Scholar
• Touitou E, Dayan N, Bergelson L, Godi B, Eliaz M. 2000. Ethosomes- novel vesicular carrier for enhanced delivery, chracterization and skin permeation properties. J Control Rel. 65:403–418.
   PubMed Web of Science ®Google Scholar
• Utreja S, Jain NK. 2001. Solid lipid nanoparticles. In: Utreja S, Jain NK, Eds. Advances in Controlled and Novel Drug Delivery. New Delhi: CBS publishers, pp. 408–425.
   Google Scholar
• Verma DD, Fahr A. 2004. Synergistic penetration effect of ethanol and phospholipids on the topical delivery of Cyclosporin A. J Control Rel. 97:55–66.
   PubMed Web of Science ®Google Scholar
• Verma MLA, Palani S. 2010. Development and in-vitro evaluation of liposomal gel of ciclopirox olamine. Int J Pharm Bio Sci. 1:1–6.
   Google Scholar
• Verma P, Pathak K. 2012. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine. 8:489–496.
   PubMed Web of Science ®Google Scholar
• Whitcher JP, Srinivasan M, Upadhyay MP. 2001. Corneal blindness: a global perspective. Bull World Health Organ. 79:214–222.
   PubMed Web of Science ®Google Scholar
• Williamson J, Gordon AM, Wood R. 1968. Fungal flora of the conjunctival sac in health and disease. Br J Ophthalmol, 52, 127–133.
   PubMed Web of Science ®Google Scholar
• Yeun CMW, Kan CW, Cheuk KL, Cheung HC, Cheng SY, Yip J, Lam PL. 2011. Development of miconazole nitrate containing chitosan microcapsules and their anti-Aspergillus niger activity. J Microencapsul. doi:10.3109/02652048.2011.642017.
   Web of Science ®Google Scholar
• Zakir F, Vaidya B, Goyal AK, Malik B, Vyas SP. 2010. Development and characterization of oleic acid vesicle for topical delivery of Fluconazole. Drug Del. 17:238–248.
   PubMed Web of Science ®Google Scholar
• Zuber T, Baddam K. 2001. Superficial fungal infection of the skin: where and how it appears help determine therapy. Postgrad Med. 109:117–132.
   PubMed Web of Science ®Google Scholar